Chemoinformaics analysis of caffeic acid 3-sulfate
| Molecular Weight | 260.223 | nRot | 4 |
| Heavy Atom Molecular Weight | 252.159 | nRig | 10 |
| Exact Molecular Weight | 259.999 | nRing | 1 |
| Solubility: LogS | -1.166 | nHRing | 0 |
| Solubility: LogP | -0.331 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 28.8783 |
| nHD | 3 | BPOL | 17.2857 |
| QED | 0.537 |
| Synth | 2.316 |
| Natural Product Likeliness | 1.176 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.826 |
| CACO-2 | -5.616 |
| MDCK | 0.0000106 |
| BBB | 0.011 |
| PPB | 0.992232 |
| VDSS | 0.243 |
| FU | 0.0165884 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.4 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.015 |
| CL | 1.619 |
| T12 | 0.783 |
| hERG | 0.007 |
| Ames | 0.005 |
| ROA | 0.531 |
| SkinSen | 0.878 |
| Carcinogencity | 0.053 |
| EI | 0.974 |
| Respiratory | 0.93 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.884669 |